Description
The global economic crisis and rising healthcare costs are making pricing and reimbursement for medical devices an increasingly delicate balancing act. European countries, whose healthcare is mostly state-funded, are finding it ever more challenging to meet the needs of a growing elderly population. In parallel, new healthcare legislation in the USA, will see payers, employers, and group purchasing organisations reigning in health care costs. Hospitals will negotiate harder for better prices on medical devices as DRG payments for procedures continue to shrink and their own costs continue to rise.
